L'objectif de notre travail a consisté en l'étude des mécanismes enzymatiques impliqués dans la libération de l'oxyde nitrique à partir des S-nitrosothiols (RSNO) et dans leurs effets vasorelaxants. Notre intérêt porte sur deux enzymes : la gamma-glutamyltransférase (GGT) et la protéine disulfure isomérase (PDI) car elles jouent un rôle important dans la dénitrosation des RSNO. Nous avons choisi d'étudier la dénitrosation de deux RSNO : le S-nitrosoglutathion (GSNO), un mononitrosothiol endogène et la S,S'-dinitrosobucillamine (BUC(NO)2), un nouveau dinitrosothiol. Nous avons synthétisé ces RSNO et nous avons vérifié la nature du produit obtenu par une caractérisation physico-chimique complète. Les analyses ont montré que ces RSNO présentent une pureté élevée (>97%) avec un niveau faible d'impuretés permettant leur utilisation dans des expérimentations biologiques. Les effets vasorelaxants des RSNO ainsi que l'implication des enzymes ont été évalués. Nos résultats montrent que la GGT et la PDI sont capables de dénitroser in vitro le GSNO. Le modèle ex vivo d'anneau aortique isolé de rat Wistar nous a permis de démontrer que l'effet vasorelaxant de GSNO (CE50=3,2±0,5.10-7 M) est dépendant de l'endothélium et de l'activité de la GGT et de la PDI. Concernant la BUC(NO)2, ce dinitrosothiol est catabolisé in vitro par la PDI, est un vasorelaxant plus puissant que la plupart des RSNO (CE50=2,2±0,2.10-8 M) et met en jeu l'activité de la PDI vasculaire. Nos travaux ont conduit à une meilleure compréhension des mécanismes enzymatiques impliqués dans les effets vasculaires des RSNO, ce qui permettra d'optimiser le choix de la meilleure RSNO à utiliser dans une finalité thérapeutique / The aim of our work was to evaluate the enzymatic pathways involved in the release of nitric oxide and in the vasorelaxant effect of S-nitrosothiols (RSNO). We were interested in two enzymes: the gamma-glutamyltransferase (GGT) and the protein disulfide isomerase (PDI), because they play an important role in RSNO denitrosation. Two RSNO were studied: S-nitrosoglutathione (GSNO), an endogenous mononitrosothiol, and S,S'-dinitrosobucillamine (BUC(NO)2), a new dinitrosothiol. We synthesized RSNO and we structurally characterized these products. The resulting data are consistent with the expected structure. Our products have a high purity (>97%) and a limited amount of impurities allowing their suitable use in biological experiments. The vasorelaxant effects of RSNO and the involvement of GGT and PDI were evaluated. The results indicate that purified GGT and PDI denitrosate GSNO in vitro. Furthermore, we demonstrated by using an ex vivo model consisting in an aortic ring isolated from Wistar rat that the vasorelaxant effect of GSNO (EC50=3,2±0,5.10-7 M) was dependent on the endothelium and GGT and PDI activities. As concerns BUC(NO)2, this dinitrosothiol catabolized in vitro by PDI, is more potent (EC50=2,2±0,2.10-8 M) than the most of nitrosothiols described in the literature. This vasorelaxation effect was dependent on PDI activity. In conclusion, our data led to a better understanding of the enzymatic mechanisms involved in the vascular effects of RSNO, which will permit, in physiopathological context, to optimize the choice of the best RSNO for use in a therapeutic purpose

Nitric Oxide (NO) has been known for long to regulate vessel tone. However, the close proximity of the site of NO production to “sinks” of NO such as hemoglobin (Hb) in blood suggest that blood will scavenge most of the NO produced. Therefore, it is unclear how NO is able to play its physiological roles. The current study deals with means by which this could be understood. Towards studying the role of nitrosothiols and nitrite in preserving NO availability, a study of the kinetics of glutathione (GSH) nitrosation by NO donors in aerated buffered solutions was undertaken first. Results suggest an increase in the rate of the corresponding nitrosothiol (GSNO) formation with an increase in GSH with a half-maximum constant EC50 that depends on NO concentration, thus indicating a significant contribution of ∙NO2 mediated nitrosation in the production of GSNO. Next, the ability of nitrite to be reduced to NO in the smooth muscle cells was evaluated. The NO formed was inhibited by sGC inhibitors and accelerated by activators and was independent of O2 concentration. Nitrite transport mechanisms and effects of exogenous nitrate on transport and reduction of nitrite were examined. The results showed that sGC can mediate nitrite reduction to NO and nitrite is transported across the smooth muscle cell membrane via anion channels, both of which can be attenuated by nitrate. Finally, a 2 – D axisymmetric diffusion model was constructed to test the accumulation of NO in the smooth muscle layer from reduction of nitrite. It was observed that at the end of the simulation period with physiological concentrations of nitrite in the smooth muscle cells (SMC), a low sustained NO generated from nitrite reduction could maintain significant sGC activity and might affect vessel tone. The major nitrosating mechanism in the circulation at reduced O2 levels was found to be anaerobic and a Cu+ dependent GSNO reduction activity was found to deliver minor amounts of NO from physiological GSNO levels in the tissue.

Made available in DSpace on 2015-07-22T20:49:20Z (GMT). No. of bitstreams: 0 Previous issue date: 2012-02-29. Added 1 bitstream(s) on 2015-08-11T03:26:18Z : No. of bitstreams: 1 Publico-13280.pdf: 1828173 bytes, checksum: df8fb9928c37e920c5f9a2281ba9c092 (MD5) / O presente trabalho trata do estudo conformacional de S-nitrosotióis com potencial atividade biológica, 2–acetamido-3-metil-3-nitrosossulfanil-N-arilbutanamidas, e de seus tióis precursores, 2–acetamido-3-mercapto-3-metil-N-arilbutanamidas. As conformações de menor energia dos S-nitrosotióis e tióis em estudo são estabilizadas por ligações de hidrogênio intramoleculares que promovem uma maior estabilidade dos confôrmeros. A análise geométrica do grupo R-SNO mostra que esses compostos preferem a conformação trans. O cálculo das interações orbitalares pelo método NBO (Natural Bond Orbital) para as 2–acetamido-3-mercapto-3-metil-N-arilbutanamidas mostrou que as mesmas são estabilizadas pelas seguintes interações: no (N2) →  (C3-O4) e no(N10) → (C11-O12). Os resultados de NBO para os S-nitrosotíois mostraram que a interação hiperconjugativa é bastante efetiva nas conformações estáveis desses compostos, enfraquecendo a ligação que resulta no aumento do comprimento da ligação S-N em S-Nitrosotióis. A forte delocalização , induz caráter parcial a ligação S-N. A fraca ligação S-N indica uma forte delocalização do par de elétrons do O(NO) devido a interação, que é responsável pelo alongamento da ligação S-N, aumentando e a potencial capacidade do óxido nítrico ser liberado. / We carried out a conformational study on the S-nitrosothiols (R-SNO), 2-acetamido-3-methyl-3-(nitrososulfanyl)-N-arylbutanamides and their thiol precursors 2-acetamido-3-mercapto-3-methyl-N-arylbutanamides. The lowest energy conformation for both compounds is stabilized by intramolecular hydrogen bonds. Trans conformation was determined as the predominant conformation after geometrical analysis of R-SNO. Orbital interactions for 2-acetamido-3-mercapto-3-methyl-N-arylbutanamides were calculated using Natural Bond Orbital (NBO) methodology. Calculations indicated that orbital interactions for these compounds are stabilized by the following interactions: no (N2) →  (C3-O4) and no(N10) → (C11-O12). NBO results showed that the hyperconjugative interaction is very effective, weakening the σ bond and resulting in increasing length of the S-N bond in R-SNO. The strong delocalization induces partial character to the S-N bond. The bond S-N indicates a strong delocalization of the electron pair of O(NO) due to interaction. This interaction is responsible for the elongation of the S-N bond which increases the ability of the compound to release nitric oxide (NO). Based on the enhanced capacity to release NO by these compounds, our findings suggest that both compounds may display biological activity. / TEDE / BV UNIFESP: Teses e dissertações

S'ha desenvolupat una nova estratègia per la síntesi ràpida i eficient de L-[metil-11C]metionina basada en el captive solvent method. La reacció de L-homocisteína (dissolució bàsica en aigua/etanol 1:1) amb [11C]CH3I en un loop de HPLC va permetre la formació del radiotraçador desitjat amb elevat rendiment radioquímic (38.4 ± 4.1%) en un temps curt (< 12 min). Tots el paràmetres analítics compleixen les especificacions requerides per la versió actual de la Farmacopea Espanyola, tot i que els valors d'activitat específica obtinguts van ser relativament baixos. Degut a això, es van estudiar i quantificar les principals fonts que contribueixen a la contaminació de carboni-12 durant les síntesis de [11C]CH3I efectuades segons el "wet" method. Es va observar que la principal font de contaminació de CO2 no radioactiu (contribució>90%) és el propi procés de bombardeig, probablement degut a la combustió (causada per les altes temperatures i pressions assolides durant la irradiació) dels compostos que contenen carboni i que es troben al gas irradiat (o a l'interior del blanc). Es van establir procediments generals per realitzar abans, durant i després de la radiosíntesi per prevenir la contaminació exterior i, d'aquesta manera, augmentar l'activitat específica dels radiotraçadors sintetitzats.En quant al marcatge amb nitrogen-13, s'ha desenvolupat un procés totalment automàtic per a la producció de [13N]NO2- a partir de [13N]NO3- generat en el ciclotró. El precursor radioactiu [13N]NO2- s'ha utilitzat per la radiosíntesi de compostos amb interès biològic com ara S-nitrosotiols (donadors de NO.), N-nitrosamines (molècules amb potencials efectes carcinogènics) i azo compostos (amb possible aplicació com a radiotraçadors per a la detecció in vivo de plaques de &#946;-amiloide). En tots els casos es van obtenir excel·lents conversions radioquímiques (48.7% - 74.5% per S-[13N]nitrosotiols, 45.6% - 53.4% per N-[13N]nitrosamines i 40.0% - 58.3% per 13N-azo compostos) i bons rendiments radioquímics (33.8% - 60.6% per S-[13N]nitrosotiols, 34.0% - 37.8% per N-[13N]nitrosamines i 20.4% - 47.2% per 13N-azo compostos). A més a més, s'ha dissenyat i implementat un mòdul automàtic amb control remot pel marcatge de molècules amb 13N. / Se ha desarrollado una nueva estrategia para la síntesis rápida y eficiente de L-[metil-11C]metionina basada en el captive solvent method. La reacción de L-homocisteína (disolución básica en agua/etanol 1:1) con [11C]CH3I en un loop de HPLC permitió la formación del radiotrazador deseado con elevado rendimiento radioquímico (38.4 ± 4.1%) en un tiempo corto (< 12 min). Todos los parámetros analíticos cumplían las especificaciones requeridas por la versión actual de la Farmacopea Española, aunque los valores de actividad específica obtenidos fueron relativamente bajos. Por ello, se estudiaron y cuantificaron las principales fuentes que contribuyen a la contaminación de carbono-12 durante las síntesis de [11C]CH3I efectuadas según el "wet" method. Se observó que la principal fuente de contaminación de CO2 no radiactivo (contribución>90%) es el propio proceso de bombardeo, probablemente debido a la combustión (causada por las altas temperaturas y presiones alcanzadas durante la irradiación) de los compuestos que contienen carbono y que se encuentran presentes en el gas irradiado (o en el mismo cuerpo del blanco). Se establecieron procedimientos generales para realizar antes, durante y con posterioridad a la radiosíntesis para prevenir la contaminación exterior y, de esta manera, aumentar la actividad específica de los radiotrazadores sintetizados.Respecto al marcaje con nitrógeno-13, se ha desarrollado un proceso totalmente automático para la producción de [13N]NO2- a partir del [13N]NO3- generado en el ciclotrón. El precursor radiactivo [13N]NO2- se ha utilizado para la radiosíntesis de compuestos con interés biológico tales como S-nitrosotioles (donadores de NO.), N-nitrosaminas (moléculas con potenciales efectos carcinogénicos) y azo compuestos (con posible aplicación como radiotrazadores para la detección in vivo de placas de &#946;-amiloide). En todos los casos se obtuvieron excelentes conversiones radioquímicas (48.7% - 74.5% para S-[13N]nitrosotioles, 45.6% - 53.4% para N-[13N]nitrosaminas y 40.0% - 58.3% para 13N-azo compuestos) y buenos rendimientos radioquímicos (33.8% - 60.6% para S-[13N]nitrosotioles, 34.0% - 37.8% para N-[13N]nitrosaminas y 20.4% - 47.2% para 13N-azo compuestos). Además, se ha diseñado e implementado un módulo automático con control remoto para el marcaje de moléculas con 13N. / A new strategy for the fast and efficient synthesis of L-[methyl-11C]methionine based on the captive solvent method has been developed. The in loop reaction of a basic water/ethanol 1:1 solution of L-homocysteine with [11C]CH3I led to the formation of the desired radiotracer with high radiochemical yield (38.4 ± 4.1%) in short production time (< 12 min). All analytical parameters were within the specifications of the current version of the Spanish Pharmacopoeia, although specific radioactivity values were relatively low. Thus, the main sources of carbon-12 during the synthesis of [11C]CH3I by the "wet" method were studied and the contribution attributable to each individual source was quantified. The most relevant contamination of non-radioactive CO2 (contribution>90%) was shown to be generated during the bombardment process, probably due to the combustion (caused by high temperature and pressure during irradiation) of carbon carrier compounds present in the irradiated gas (or target body). General procedures to be performed before, during and after the radiosynthesis were established to prevent external contamination and to improve the specific radioactivity of 11C-labeled radiotracers synthesized from [11C]CH3I produced via the "wet" method. Concerning 13N-labeling, a fully automatic process for the production of [13N]NO2- from cyclotron generated [13N]NO3- has been developed. The radioactive precursor [13N]NO2- has been used for the synthesis of biologically interesting 13N-labeled compounds such as S-nitrosothiols (well-known NO. donors), N-nitrosamines (molecules with potent carcinogenic effects) and azo compounds (with putative application as imaging probes for in vivo detection of &#946;-amyloid plaques). In all cases, excellent radiochemical conversion (48.7% - 74.5% for S-[13N]nitrosothiols, 45.6% - 53.4% for N-[13N]nitrosamines and 40.0% - 58.3% for 13N-labeled azo compounds) and good radiochemical yields (33.8% - 60.6% for S-[13N]nitrosothiols, 34.0% - 37.8% for N-[13N]nitrosamines and 20.4% - 47.2% for 13N-labeled azo compounds) were achieved. An automatic remote controlled synthesis module for the preparation of 13N-labeled structures has been designed and implemented.